Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. (ONCSM) - Total Assets
Based on the latest financial reports, Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. (ONCSM) holds total assets worth TL384.37 Million TRY (≈ $8.61 Million USD) as of September 2024. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Check Oncosem Onkolojik Sistemler Sanayi ve Ti cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. - Total Assets Trend (2020–2023)
This chart illustrates how Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S.'s total assets have evolved over time, based on quarterly financial data. Check Oncosem Onkolojik Sistemler Sanayi ve Ti cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. - Asset Composition Analysis
Current Asset Composition (December 2023)
Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S.'s total assets of TL384.37 Million consist of 57.7% current assets and 42.3% non-current assets.
| Asset Category | Amount (TRY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | TL0.00 | 17.3% |
| Accounts Receivable | TL54.41 Million | 16.1% |
| Inventory | TL77.64 Million | 23.0% |
| Property, Plant & Equipment | TL0.00 | 0.0% |
| Intangible Assets | TL4.85 Million | 1.4% |
| Goodwill | TL0.00 | 0.0% |
Asset Composition Trend (2020–2023)
This chart illustrates how Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S.'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see ONCSM stock market capitalisation.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S.'s current assets represent 57.7% of total assets in 2023, an increase from 31.7% in 2020.
- Cash Position: Cash and equivalents constituted 17.3% of total assets in 2023, up from 6.4% in 2020.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 1.0% of total assets, an increase from 0.0% in 2020.
- Asset Diversification: The largest asset category is inventory at 23.0% of total assets.
Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. Competitors by Total Assets
Key competitors of Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥5.03 Billion |
|
Shenzhen New Industries Biomedical
SHE:300832
|
China | CN¥9.58 Billion |
|
4DMEDICAL Ltd
AU:4DX
|
Australia | AU$139.55 Million |
|
Shanghai MicroPort EV MedTech Co. Ltd. A
SHG:688351
|
China | CN¥2.00 Billion |
|
L&C Bio Co. Ltd
KQ:290650
|
Korea | ₩497.94 Billion |
|
INKON Life Technology Co Ltd
SHE:300143
|
China | CN¥4.17 Billion |
|
Shenzhen Lifotronic Technology Co
SHG:688389
|
China | CN¥2.53 Billion |
|
SS Innovations International Inc. Common Stock
NASDAQ:SSII
|
USA | $90.55 Million |
Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.15 | 2.84 | 2.84 |
| Quick Ratio | 1.42 | 2.02 | 2.02 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | TL118.21 Million | TL117.53 Million | TL117.53 Million |
Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. - Advanced Valuation Insights
This section examines the relationship between Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S.'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 15.47 |
| Latest Market Cap to Assets Ratio | 0.41 |
| Asset Growth Rate (YoY) | -3.2% |
| Total Assets | TL338.31 Million |
| Market Capitalization | $139.02 Million USD |
Valuation Analysis
Below Book Valuation: The market values Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S.'s assets below their book value (0.41x), which may indicate investor concerns about asset quality or future growth.
Slight Asset Contraction: Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S.'s assets decreased by 3.2% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. (2020–2023)
The table below shows the annual total assets of Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. from 2020 to 2023.
| Year | Total Assets | Change |
|---|---|---|
| 2023-12-31 | TL338.31 Million ≈ $7.58 Million |
-3.22% |
| 2022-12-31 | TL349.58 Million ≈ $7.83 Million |
+169.84% |
| 2021-12-31 | TL129.55 Million ≈ $2.90 Million |
-1.95% |
| 2020-12-31 | TL132.13 Million ≈ $2.96 Million |
-- |
About Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S.
Oncosem Onkolojik Sistemler Sanayi Ve Ticaret Anonim Sirketi manufactures and sells chemotherapy drug preparation kits, medical devices, and test kits in Turkey. The company offers OncoCare Monolitik, an automated chemotherapy drug preparation device; OncoCare Plus, a chemotherapy drug guide; OncoWaste and M-Waste, a hazardous waste sealing system, chemotherapy drugs, cephalosporins, penicillins,… Read more